- Global Pharma News & Resources

Alcon confirms commitment to Switzerland ahead of proposed spinoff from Novartis

Media release (PDF)

This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Novartis International AG via GlobeNewswire

Editor Details

Last Updated: 12-Sep-2018